TABETHA SPARKS: Open Payments
NPI 1619302858 · JEFFERSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 21 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $171 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $171 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| E.R. Squibb & Sons, L.L.C. | 4 | $66 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| PFIZER INC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| Corcept Therapeutics | 1 | $14 |
Products named: Ozempic, ELIQUIS, SHINGRIX, TRELEGY ELLIPTA, Rybelsus, GVOKE HYPOPEN, CAMZYOS, COMIRNATY.
Industry payments across TN — which companies pay providers there.
